Fairmed Healthcare AG’s €10 Million Senior Secured Financing From Duke Royalty Limited Close

Fairmed Healthcare AG's €10 Million Senior Secured Financing From Duke Royalty Limited Close

In UK Charles Russell Speechlys, advised on the matter.

Charles Russell Speechlys advised Duke Royalty Limited with a team including Paul Arathoon (Corporate M&A), Olivier Cavadini (Tax Finance), Susan Mitchell (Finance).

Urbach Law advised Fairmed Healthcare AG, Strides Pharma Science Limited with a team including

Fairmed Healthcare AG, Swiss generics company based in Zug, raises senior secured loan from Duke Royalty Limited.

Fairmed was founded in 2012 and is based in Zug, Switzerland. The company offers high-quality generic prescription medicines, over-the-counter medicines, dermocosmetics and nutritional supplements in various EU countries.

Fairmed is majority owned by Strides Pharma Global Pte Ltd, which in turn is a wholly owned subsidiary of Strides Pharma Science Limited, a publicly traded corporation.

Duke Royalty is the leading provider of royalty finance to companies in the UK and Europe.

The Urbach Law team was led by partner Simon Urbach (Picture) and included associates Amelie Hoffmann and Rezeda Maritz.

Banking & Finance Legal Director Susan Mitchell, assisted by Corporate Partner Paul Arathoon, Banking & Finance Partner Danny Sullivan and Swiss-based Partner Olivier Cavadini, led the Charles Russell Speechlys team. Noerr advised Duke Royalty on German law aspects.

Involved fees earner: Paul Arathoon – Charles Russell Speechlys; Olivier Cavadini – Charles Russell Speechlys; Susan Mitchell – Charles Russell Speechlys; Daniel Sullivan – Charles Russell Speechlys; Amelie Hoffmann – Urbach Law; Rezeda Maritz – Urbach Law; Simon Urbach – Urbach Law;

Law Firms: Charles Russell Speechlys; Urbach Law;

Clients: Duke Royalty Limited; Fairmed Healthcare AG; Strides Pharma Science Limited;

Author: Giulia Di Palma

Leave a Reply